跳至主要内容
临床试验/JPRN-UMIN000001548
JPRN-UMIN000001548已完成未知

The Evaluation of Effects against Acute- or Relapse Infarction in Patients with both Diabetes and Hypertension Taking ARB and PPAR-gammma Inhibitor - The Evaluation of Effects against Acute- or Relapse Infarction in Patients with both Diabetes and Hypertension Taking ARB and PPAR-gamma Inhibitor (ARITA Study)

HuBit genomix, Inc.0 个研究点目标入组 200 人开始时间: 2008年12月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) History of cardiac failure 2) Diagnosis of Cardiovascular disturbance and/or cerebrovascular disease within 6 months 3) Secondary hypertension 4) Type I diabetes 5) Diagnosis and/or treatment of cancer within 5 years 6) Renal dysfunction 7) Liver dysfunction 8) History of side effects of TDZ or ARB 9) No current or past history of psychiatric disorders 10) Pregnant women or lactating mothers 11) Participating another clinical investigation within 3 months 12) Patients judged by the investigator to be unfit to be enrolled into the study

研究者

发起方
HuBit genomix, Inc.

相似试验

The Evaluation of Effects against Acute- or Relapse... | 临床试验